165 related articles for article (PubMed ID: 28603216)
1. Efficacy of an avian colibacillosis live vaccine for layer breeder in Japan.
Uotani Y; Kitahara R; Imai T; Tsutsumi N; Sasakawa C; Nagai S; Nagano T
J Vet Med Sci; 2017 Jul; 79(7):1215-1219. PubMed ID: 28603216
[TBL] [Abstract][Full Text] [Related]
2. Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
Ebrahimi-Nik H; Bassami MR; Mohri M; Rad M; Khan MI
PLoS One; 2018; 13(3):e0194888. PubMed ID: 29566080
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of an aroA-deleted live vaccine against avian colibacillosis in a multicentre field trial in broilers in Morocco.
Mombarg M; Bouzoubaa K; Andrews S; Vanimisetti HB; Rodenberg J; Karaca K
Avian Pathol; 2014; 43(3):276-81. PubMed ID: 24824589
[TBL] [Abstract][Full Text] [Related]
4. An attenuated mutant of avian pathogenic Escherichia coli serovar O78: a possible live vaccine strain for prevention of avian colibacillosis.
Nagano T; Kitahara R; Nagai S
Microbiol Immunol; 2012 Sep; 56(9):605-12. PubMed ID: 22708916
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Iss as a potential vaccine for avian colibacillosis.
Lynne AM; Kariyawasam S; Wannemuehler Y; Johnson TJ; Johnson SJ; Sinha AS; Lynne DK; Moon HW; Jordan DM; Logue CM; Foley SL; Nolan LK
Avian Dis; 2012 Mar; 56(1):192-9. PubMed ID: 22545546
[TBL] [Abstract][Full Text] [Related]
6. Avian pathogenic Escherichia coli ΔtonB mutants are safe and protective live-attenuated vaccine candidates.
Holden KM; Browning GF; Noormohammadi AH; Markham P; Marenda MS
Vet Microbiol; 2014 Oct; 173(3-4):289-98. PubMed ID: 25205199
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of passive immunization in broiler chicks via an inactivated
Keita A; Le Devendec L; Amelot M; Puterflam J; Lucas C; Bougeard S; Delannoy S; Schouler C; Fach P; Lucas P; Souillard R; Kempf I
Avian Pathol; 2022 Oct; 51(5):445-456. PubMed ID: 35634647
[TBL] [Abstract][Full Text] [Related]
8. A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys.
Kwaga JK; Allan BJ; van der Hurk JV; Seida H; Potter AA
Infect Immun; 1994 Sep; 62(9):3766-72. PubMed ID: 8063392
[TBL] [Abstract][Full Text] [Related]
9. Impact of colibacillosis on production in laying hens associated with interference of the phosphotransfer network and oxidative stress.
da Rosa G; Da Silva AS; Souza CF; Baldissera MD; Mendes RE; Araujo DN; Alba DF; Boiago MM; Stefani LM
Microb Pathog; 2019 May; 130():131-136. PubMed ID: 30858007
[TBL] [Abstract][Full Text] [Related]
10. Design, development, and evaluation of the efficacy of a nucleic acid-free version of a bacterial ghost candidate vaccine against avian pathogenic E. coli (APEC) O78:K80 serotype.
Soleymani S; Tavassoli A; Hashemi Tabar G; Kalidari GA; Dehghani H
Vet Res; 2020 Dec; 51(1):144. PubMed ID: 33298146
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a live attenuated Escherichia coli O78:K80 vaccine in chickens and turkeys.
La Ragione RM; Woodward MJ; Kumar M; Rodenberg J; Fan H; Wales AD; Karaca K
Avian Dis; 2013 Jun; 57(2):273-9. PubMed ID: 24689185
[TBL] [Abstract][Full Text] [Related]
12. Use of lipopolysaccharide (LPS) as a positive control for the evaluation of immunopotentiating drug candidates in experimental avian colibacillosis models.
McGruder ED; Moore GM
Res Vet Sci; 1999 Feb; 66(1):33-7. PubMed ID: 10088709
[TBL] [Abstract][Full Text] [Related]
13. Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli.
Kariyawasam S; Wilkie BN; Gyles CL
Avian Dis; 2004; 48(2):287-99. PubMed ID: 15283416
[TBL] [Abstract][Full Text] [Related]
14. Influence of vaccination of broiler chickens against Escherichia coli with live attenuated vaccine on general properties of E. coli population, IBV vaccination efficiency, and production parameters-a field experiment.
Śmiałek M; Kowalczyk J; Koncicki A
Poult Sci; 2020 Nov; 99(11):5452-5460. PubMed ID: 33142462
[TBL] [Abstract][Full Text] [Related]
15. The design and application of a bacterial ghost vaccine to evaluate immune response and defense against avian pathogenic Escherichia coli O2:K1 serotype.
Hoseini Shahidi R; Hashemi Tabar G; Bassami MR; Jamshidi A; Dehghani H
Res Vet Sci; 2019 Aug; 125():153-161. PubMed ID: 31228739
[TBL] [Abstract][Full Text] [Related]
16. Identification of Subunits for Novel Universal Vaccines against Three Predominant Serogroups and the Emerging O145 among Avian Pathogenic Escherichia coli by Pan-RV Pipeline.
Wang Z; Xu S; Zheng X; Zheng X; Liu M; Guo G; Yu Y; Han X; Liu Y; Wang K; Zhang W
Appl Environ Microbiol; 2023 Jan; 89(1):e0106122. PubMed ID: 36533928
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of chickens with liposomal inactivated avian pathogenic Escherichia coli (APEC) vaccine by eye drop or coarse spray administration.
Yaguchi K; Ohgitani T; Noro T; Kaneshige T; Shimizu Y
Avian Dis; 2009 Jun; 53(2):245-9. PubMed ID: 19630231
[TBL] [Abstract][Full Text] [Related]
18. Immune responses to oral vaccination with Salmonella-delivered avian pathogenic Escherichia coli antigens and protective efficacy against colibacillosis.
Lee JH; Chaudhari AA; Oh IG; Eo SK; Park SY; Jawale CV
Can J Vet Res; 2015 Jul; 79(3):229-34. PubMed ID: 26130856
[TBL] [Abstract][Full Text] [Related]
19. Potential improvement of the immune response of chickens against E. coli vaccine by using two forms of chitosan nanoparticles.
Mohammed GM; ElZorkany HE; Farroh KY; Abd El-Aziz WR; Elshoky HA
Int J Biol Macromol; 2021 Jan; 167():395-404. PubMed ID: 33275976
[TBL] [Abstract][Full Text] [Related]
20. Breeding to reduce susceptibility to Escherichia coli in layers.
Cavero D; Schmutz M; Philipp HC; Preisinger R
Poult Sci; 2009 Oct; 88(10):2063-8. PubMed ID: 19762857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
